SpendRule raises $4m to wire AI contract enforcement into healthcare
SpendRule, a Dallas-based contract enforcement platform, has closed a $4 million seed round led by Mark Cuban's Radical Investments, with Zeal Capital Partners also participating. The raise brings the company's total funding to $6 million and marks one of the more strategically timed bets in enterprise software: the convergence of agentic AI procurement and the chronic contract-leakage problem in large organisations.
The company's core proposition is deceptively simple. Health systems negotiate contracts with thousands of vendors covering staffing, facilities, environmental services and IT, then largely trust that invoices reflect those agreed terms. SpendRule sits between the signed contract and the payment, reading every clause and checking each invoice against it in real time. When a discrepancy appears, both customer and vendor work from the same evidence inside the platform. The company says it currently monitors $2.91 billion in annual purchased services spend across 2,187 business relationships, with clients including OSF HealthCare, Kettering Health, MemorialCare and MUSC Health.
The agentic payments inflection point
What lifts this beyond a healthcare-specific accounts-payable tool is SpendRule's explicit positioning for an agentic AI future. As enterprises increasingly deploy AI agents to buy, approve and pay on their behalf, the question of what any given contract actually permits becomes a machine-readable infrastructure problem, not a human compliance one. SpendRule's co-founder and co-CEO Joseph Akintolayo frames it as turning "agreements and policies into deterministic decision systems that actually run." That framing puts the company in direct dialogue with the emerging agentic-workflow layer being built by foundation-model labs, hyperscalers and enterprise software platforms alike.
Mark Cuban's endorsement is pointed: "Companies spend all this time negotiating contracts, but what's the point if nobody checks whether they're getting what they paid for?" The observation is not unique to healthcare. Contract leakage, meaning the gap between negotiated terms and what is actually paid, is a well-documented problem in financial services, logistics, real estate and government procurement. SpendRule has chosen healthcare as a beachhead precisely because hospital purchased services represent some of the most legally dense, vendor-heavy contract environments in any industry.
Cross-sector and capital read-across
The macro signal here is the acceleration of what could be called the "enforcement layer" thesis: as commercial relationships grow more complex and AI agents become counterparties in procurement chains, the infrastructure for making agreements machine-enforceable becomes a distinct and valuable software category. This sits adjacent to smart-contract thinking in blockchain, but SpendRule is decidedly not crypto-native: it operates on top of conventional contracts, PDFs and invoices, making it compatible with legacy enterprise environments.
For investors tracking capital flows across healthcare technology and enterprise AI, the seed size is modest but the geometry is notable. Cuban's Radical Investments tends to back companies with clear unit economics in underserved operational niches; Zeal Capital Partners has a track record in fintech-adjacent infrastructure for underrepresented founders and markets. The combined signal is that the enforcement-layer thesis is attracting diverse capital before an obvious category leader has emerged.
The near-term roadmap points beyond healthcare. SpendRule's stated ambition is to extend its contract enforcement infrastructure to a broader range of businesses, which implies a horizontal expansion play once the healthcare beachhead is proven. For cross-sector strategists, the relevant question is sequencing: which sectors with dense vendor relationships and high invoice volumes, logistics and construction being obvious candidates, become the second wave, and whether a larger enterprise software player will attempt to acquire the category before it consolidates independently.
Co-CEO Chris Heckler summarises the healthcare case with characteristic directness: "Every dollar lost to a billing mismatch is a dollar that didn't go to care."